Aurobindo Pharma to commence supplies to Europe from China plant in April

Aurobindo Pharma will start supplying products from its new China facility to Europe by April 2024. The company is ramping up production after receiving European regulatory approvals. Plans to enter the US market are also in progress. Aurobindo expects significant revenue growth from this facility over the next two to three years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WQ6hTwg
via IFTTT